Editor's Choice Archive
Editor's Choice By Date
Stemline therapeutics, a subsidiary of menarini group, receives u.s. Fda approval for orserdu™ (elacestrant) as the first and only treatment specifically indicated for patients with esr1 mutations in er+, her2- advanced or metastatic breast cancer
Danicopan as add-on to ULTOMIRIS® or SOLIRIS® improved hemoglobin levels and maintained disease control in patients with PNH experiencing signs or symptoms of clinically significant extravascular hemolysis
Certest Biotec, the University of Zaragoza and the University of the Basque Country are working on developing a new inhaled vaccine against tuberculosis, as a reinforcement of the current and future vaccines
Randox Laboratories introduces Prostate-specific Antigen (PSA). This allows testing for indications of prostate cancer and other prostate conditions such as prostatitis and benign prostatic hyperplasia.
Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
Africa Health ExCon-2023: The Egyptian Authority for Unified Procurement (UPA) and the Arab Hospital Federation (AHF) signed a protocol on cooperation to consolidate the role of the Africa Health ExCon